IMS: China Pharma Revenues to Total $155-$185 Billion in 2018

According to a new IMS Health report, China is already the world's second largest pharmaceutical market, and it will spend between $155 billion and $185 billion on drugs in 2018. IMS says China's citizens will expect more and better healthcare, raising revenues, but the government will apply pressure on costs, restraining overall spending levels. In addition, the health consultancy believes drug spending in 21 "pharmerging" countries will rise 50% by 2018 over 2013 levels. More details.... Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.